<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sauter</surname>
    <given-names>I. P.</given-names>
   </name>
   <name>
    <surname>Madrid</surname>
    <given-names>K. G.</given-names>
   </name>
   <name>
    <surname>de Assis</surname>
    <given-names>J. B.</given-names>
   </name>
   <name>
    <surname>SÃ¡-Nunes</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Torrecilhas</surname>
    <given-names>A. C.</given-names>
   </name>
   <name>
    <surname>Staquicini</surname>
    <given-names>D. I.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in 
   <italic>Leishmania</italic> infection
  </article-title>. 
  <source>JCI Insight</source>
  <volume>4</volume> (
  <issue>10</issue>), 
  <fpage>e126207</fpage>
  <pub-id pub-id-type="doi">10.1172/jci.insight.126207</pub-id>
 </mixed-citation>
</ref>
